Stock data
Silo Pharma, Inc. (SILO)
Silo Pharma, Inc. (SILO) reported revenue of US$0.07M and net income of -US$4.23M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.07M | US$0.03M | -US$4.28M | -US$4.23M | — |
| 2024 | US$0.07M | US$0.07M | -US$4.71M | -US$4.39M | — |
| 2023 | US$0.07M | US$0.07M | -US$3.86M | -US$3.70M | — |
| 2022 | US$0.07M | US$0.07M | -US$3.63M | -US$3.91M | — |
| 2021 | — | US$0.07M | -US$2.74M | US$3.90M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$0.83M | — |
| 2026-03-31 | US$0.02M | -US$1.65M | — |
| 2025-12-31 | US$0.02M | -US$0.88M | — |
| 2025-09-30 | US$0.02M | -US$1.11M | — |
| 2025-06-30 | US$0.02M | -US$1.20M | — |
| 2025-03-31 | US$0.02M | -US$1.03M | — |
| 2024-12-31 | US$0.02M | -US$1.73M | — |
| 2024-09-30 | US$0.02M | -US$0.93M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.